ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Injection General Anesthesia Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19E13381
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Intravenous Injection General Anesthesia Drugs Market Research Report 2023
BUY CHAPTERS

Global Intravenous Injection General Anesthesia Drugs Market Research Report 2025

Code: QYRE-Auto-19E13381
Report
May 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aspen Pharma
Fresenius Kabi
AbbVie
Baxter Healthcare
B. Braun
Piramal
Hikma Pharmaceuticals
Astrazeneca plc
Nhwa
Hengrui
Yichang Humanwell
Lunan Pharmaceutical Group Corporation
Xi'an Libang
China National Medicines Guorui Pharmaceutical Co.,Ltd.
Maruishi

Intravenous Injection General Anesthesia Drugs Market Size

The global market for Intravenous Injection General Anesthesia Drugs was valued at US$ 1790 million in the year 2024 and is projected to reach a revised size of US$ 2729 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Intravenous Injection General Anesthesia Drugs Market

Intravenous Injection General Anesthesia Drugs Market

Intravenous general anesthesia refers to a method in which one or several drugs are injected intravenously and act on the central nervous system through blood circulation to produce general anesthesia. According to different administration methods, intravenous anesthesia can be divided into single administration method, divided administration method and continuous administration method. Due to some limitations of its own, the use of intravenous general anesthesia was once limited. However, since the 1980s, with the continuous improvement of clinical pharmacology research methods, the development of new strong and short-acting intravenous anesthetics and the advent of computerized intravenous automatic drug delivery systems, intravenous anesthesia has been greatly improved. And development, has now become the mainstream general anesthesia solution.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Injection General Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Injection General Anesthesia Drugs.
The Intravenous Injection General Anesthesia Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Injection General Anesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Injection General Anesthesia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous Injection General Anesthesia Drugs Market Report

Report Metric Details
Report Name Intravenous Injection General Anesthesia Drugs Market
Accounted market size in year US$ 1790 million
Forecasted market size in 2031 US$ 2729 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hopitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, AstraZeneca, Nhwa, Hengrui, Xi'an Libang, Yichang Humanwell, China National Medicines Guorui Pharmaceutical Co.,Ltd., Lunan Pharmaceutical Group Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intravenous Injection General Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intravenous Injection General Anesthesia Drugs Market growing?

Ans: The Intravenous Injection General Anesthesia Drugs Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Intravenous Injection General Anesthesia Drugs Market size in 2031?

Ans: The Intravenous Injection General Anesthesia Drugs Market size in 2031 will be US$ 2729 million.

Who are the main players in the Intravenous Injection General Anesthesia Drugs Market report?

Ans: The main players in the Intravenous Injection General Anesthesia Drugs Market are Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, AstraZeneca, Nhwa, Hengrui, Xi'an Libang, Yichang Humanwell, China National Medicines Guorui Pharmaceutical Co.,Ltd., Lunan Pharmaceutical Group Corporation

What are the Application segmentation covered in the Intravenous Injection General Anesthesia Drugs Market report?

Ans: The Applications covered in the Intravenous Injection General Anesthesia Drugs Market report are Hopitals, Clinics, Others

What are the Type segmentation covered in the Intravenous Injection General Anesthesia Drugs Market report?

Ans: The Types covered in the Intravenous Injection General Anesthesia Drugs Market report are Propofol, Sevoflurane, Remifentanil, Etomidate, Isoflurane, Other

Recommended Reports

General Anesthetics

Anesthesia Devices

Local Anesthetics

1 Intravenous Injection General Anesthesia Drugs Market Overview
1.1 Product Definition
1.2 Intravenous Injection General Anesthesia Drugs by Type
1.2.1 Global Intravenous Injection General Anesthesia Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Remifentanil
1.2.5 Etomidate
1.2.6 Isoflurane
1.2.7 Other
1.3 Intravenous Injection General Anesthesia Drugs by Application
1.3.1 Global Intravenous Injection General Anesthesia Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hopitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Intravenous Injection General Anesthesia Drugs Market Size Estimates and Forecasts
1.4.1 Global Intravenous Injection General Anesthesia Drugs Revenue 2020-2031
1.4.2 Global Intravenous Injection General Anesthesia Drugs Sales 2020-2031
1.4.3 Global Intravenous Injection General Anesthesia Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous Injection General Anesthesia Drugs Market Competition by Manufacturers
2.1 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous Injection General Anesthesia Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous Injection General Anesthesia Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Product Type & Application
2.7 Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Date of Enter into This Industry
2.8 Global Intravenous Injection General Anesthesia Drugs Market Competitive Situation and Trends
2.8.1 Global Intravenous Injection General Anesthesia Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous Injection General Anesthesia Drugs Players Market Share by Revenue
2.8.3 Global Intravenous Injection General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Injection General Anesthesia Drugs Market Scenario by Region
3.1 Global Intravenous Injection General Anesthesia Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2020-2031
3.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2020-2025
3.2.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2026-2031
3.3 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2020-2031
3.3.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2020-2025
3.3.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2026-2031
3.4 North America Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
3.4.1 North America Intravenous Injection General Anesthesia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2031)
3.4.3 North America Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
3.5.1 Europe Intravenous Injection General Anesthesia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2031)
3.5.3 Europe Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Injection General Anesthesia Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
3.7.1 Latin America Intravenous Injection General Anesthesia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2031)
3.7.3 Latin America Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2020-2031)
4.1.1 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2020-2025)
4.1.2 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2026-2031)
4.1.3 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2020-2031)
4.2.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2020-2025)
4.2.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2026-2031)
4.2.3 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous Injection General Anesthesia Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2020-2031)
5.1.1 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2020-2025)
5.1.2 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2026-2031)
5.1.3 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2020-2031)
5.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2020-2031)
5.2.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2020-2025)
5.2.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2026-2031)
5.2.3 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous Injection General Anesthesia Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aspen Pharma
6.1.1 Aspen Pharma Company Information
6.1.2 Aspen Pharma Description and Business Overview
6.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio
6.1.5 Aspen Pharma Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Company Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Company Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B.Braun
6.5.1 B.Braun Company Information
6.5.2 B.Braun Description and Business Overview
6.5.3 B.Braun Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio
6.5.5 B.Braun Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Company Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.7.1 Piramal Company Information
6.7.2 Piramal Description and Business Overview
6.7.3 Piramal Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Company Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Company Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Company Information
6.11.2 Hengrui Description and Business Overview
6.11.3 Hengrui Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Xi'an Libang
6.12.1 Xi'an Libang Company Information
6.12.2 Xi'an Libang Description and Business Overview
6.12.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio
6.12.5 Xi'an Libang Recent Developments/Updates
6.13 Yichang Humanwell
6.13.1 Yichang Humanwell Company Information
6.13.2 Yichang Humanwell Description and Business Overview
6.13.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio
6.13.5 Yichang Humanwell Recent Developments/Updates
6.14 China National Medicines Guorui Pharmaceutical Co.,Ltd.
6.14.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
6.14.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Description and Business Overview
6.14.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio
6.14.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.15 Maruishi
6.15.1 Maruishi Company Information
6.15.2 Maruishi Description and Business Overview
6.15.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
6.15.5 Maruishi Recent Developments/Updates
6.16 Lunan Pharmaceutical Group Corporation
6.16.1 Lunan Pharmaceutical Group Corporation Company Information
6.16.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
6.16.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio
6.16.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Injection General Anesthesia Drugs Industry Chain Analysis
7.2 Intravenous Injection General Anesthesia Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Injection General Anesthesia Drugs Production Mode & Process Analysis
7.4 Intravenous Injection General Anesthesia Drugs Sales and Marketing
7.4.1 Intravenous Injection General Anesthesia Drugs Sales Channels
7.4.2 Intravenous Injection General Anesthesia Drugs Distributors
7.5 Intravenous Injection General Anesthesia Drugs Customer Analysis
8 Intravenous Injection General Anesthesia Drugs Market Dynamics
8.1 Intravenous Injection General Anesthesia Drugs Industry Trends
8.2 Intravenous Injection General Anesthesia Drugs Market Drivers
8.3 Intravenous Injection General Anesthesia Drugs Market Challenges
8.4 Intravenous Injection General Anesthesia Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Aspen Pharma
Fresenius Kabi
AbbVie
Baxter Healthcare
B. Braun
Piramal
Hikma Pharmaceuticals
Astrazeneca plc
Nhwa
Hengrui
Yichang Humanwell
Lunan Pharmaceutical Group Corporation
Xi'an Libang
China National Medicines Guorui Pharmaceutical Co.,Ltd.
Maruishi
List of Tables
 Table 1. Global Intravenous Injection General Anesthesia Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intravenous Injection General Anesthesia Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intravenous Injection General Anesthesia Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intravenous Injection General Anesthesia Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intravenous Injection General Anesthesia Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intravenous Injection General Anesthesia Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intravenous Injection General Anesthesia Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intravenous Injection General Anesthesia Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravenous Injection General Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Injection General Anesthesia Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous Injection General Anesthesia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Intravenous Injection General Anesthesia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intravenous Injection General Anesthesia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intravenous Injection General Anesthesia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intravenous Injection General Anesthesia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intravenous Injection General Anesthesia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intravenous Injection General Anesthesia Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intravenous Injection General Anesthesia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intravenous Injection General Anesthesia Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Intravenous Injection General Anesthesia Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Intravenous Injection General Anesthesia Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intravenous Injection General Anesthesia Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Intravenous Injection General Anesthesia Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intravenous Injection General Anesthesia Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intravenous Injection General Anesthesia Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Intravenous Injection General Anesthesia Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Intravenous Injection General Anesthesia Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intravenous Injection General Anesthesia Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Intravenous Injection General Anesthesia Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intravenous Injection General Anesthesia Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Aspen Pharma Company Information
 Table 71. Aspen Pharma Description and Business Overview
 Table 72. Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product
 Table 74. Aspen Pharma Recent Developments/Updates
 Table 75. Fresenius-Kabi Company Information
 Table 76. Fresenius-Kabi Description and Business Overview
 Table 77. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product
 Table 79. Fresenius-Kabi Recent Developments/Updates
 Table 80. AbbVie Company Information
 Table 81. AbbVie Description and Business Overview
 Table 82. AbbVie Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AbbVie Intravenous Injection General Anesthesia Drugs Product
 Table 84. AbbVie Recent Developments/Updates
 Table 85. Baxter Healthcare Company Information
 Table 86. Baxter Healthcare Description and Business Overview
 Table 87. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product
 Table 89. Baxter Healthcare Recent Developments/Updates
 Table 90. B.Braun Company Information
 Table 91. B.Braun Description and Business Overview
 Table 92. B.Braun Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. B.Braun Intravenous Injection General Anesthesia Drugs Product
 Table 94. B.Braun Recent Developments/Updates
 Table 95. Maruishi Company Information
 Table 96. Maruishi Description and Business Overview
 Table 97. Maruishi Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Maruishi Intravenous Injection General Anesthesia Drugs Product
 Table 99. Maruishi Recent Developments/Updates
 Table 100. Piramal Company Information
 Table 101. Piramal Description and Business Overview
 Table 102. Piramal Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Piramal Intravenous Injection General Anesthesia Drugs Product
 Table 104. Piramal Recent Developments/Updates
 Table 105. Hikma Pharmaceuticals Company Information
 Table 106. Hikma Pharmaceuticals Description and Business Overview
 Table 107. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product
 Table 109. Hikma Pharmaceuticals Recent Developments/Updates
 Table 110. AstraZeneca Company Information
 Table 111. AstraZeneca Description and Business Overview
 Table 112. AstraZeneca Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. AstraZeneca Intravenous Injection General Anesthesia Drugs Product
 Table 114. AstraZeneca Recent Developments/Updates
 Table 115. Nhwa Company Information
 Table 116. Nhwa Description and Business Overview
 Table 117. Nhwa Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Nhwa Intravenous Injection General Anesthesia Drugs Product
 Table 119. Nhwa Recent Developments/Updates
 Table 120. Hengrui Company Information
 Table 121. Hengrui Description and Business Overview
 Table 122. Hengrui Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hengrui Intravenous Injection General Anesthesia Drugs Product
 Table 124. Hengrui Recent Developments/Updates
 Table 125. Xi'an Libang Company Information
 Table 126. Xi'an Libang Description and Business Overview
 Table 127. Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Xi'an Libang Intravenous Injection General Anesthesia Drugs Product
 Table 129. Xi'an Libang Recent Developments/Updates
 Table 130. Yichang Humanwell Company Information
 Table 131. Yichang Humanwell Description and Business Overview
 Table 132. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product
 Table 134. Yichang Humanwell Recent Developments/Updates
 Table 135. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
 Table 136. China National Medicines Guorui Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 137. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product
 Table 139. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 140. Maruishi Company Information
 Table 141. Maruishi Description and Business Overview
 Table 142. Maruishi Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Maruishi Intravenous Injection General Anesthesia Drugs Product
 Table 144. Maruishi Recent Developments/Updates
 Table 145. Lunan Pharmaceutical Group Corporation Company Information
 Table 146. Lunan Pharmaceutical Group Corporation Description and Business Overview
 Table 147. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product
 Table 149. Lunan Pharmaceutical Group Corporation Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Intravenous Injection General Anesthesia Drugs Distributors List
 Table 153. Intravenous Injection General Anesthesia Drugs Customers List
 Table 154. Intravenous Injection General Anesthesia Drugs Market Trends
 Table 155. Intravenous Injection General Anesthesia Drugs Market Drivers
 Table 156. Intravenous Injection General Anesthesia Drugs Market Challenges
 Table 157. Intravenous Injection General Anesthesia Drugs Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravenous Injection General Anesthesia Drugs
 Figure 2. Global Intravenous Injection General Anesthesia Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intravenous Injection General Anesthesia Drugs Market Share by Type: 2024 & 2031
 Figure 4. Propofol Product Picture
 Figure 5. Sevoflurane Product Picture
 Figure 6. Remifentanil Product Picture
 Figure 7. Etomidate Product Picture
 Figure 8. Isoflurane Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Intravenous Injection General Anesthesia Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Intravenous Injection General Anesthesia Drugs Market Share by Application: 2024 & 2031
 Figure 12. Hopitals
 Figure 13. Clinics
 Figure 14. Others
 Figure 15. Global Intravenous Injection General Anesthesia Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Intravenous Injection General Anesthesia Drugs Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Intravenous Injection General Anesthesia Drugs Sales (2020-2031) & (K Units)
 Figure 18. Global Intravenous Injection General Anesthesia Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 19. Intravenous Injection General Anesthesia Drugs Report Years Considered
 Figure 20. Intravenous Injection General Anesthesia Drugs Sales Share by Manufacturers in 2024
 Figure 21. Global Intravenous Injection General Anesthesia Drugs Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Intravenous Injection General Anesthesia Drugs Players: Market Share by Revenue in Intravenous Injection General Anesthesia Drugs in 2024
 Figure 23. Intravenous Injection General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Intravenous Injection General Anesthesia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2020-2031)
 Figure 26. North America Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. United States Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2020-2031)
 Figure 30. Europe Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2020-2031)
 Figure 38. China Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Intravenous Injection General Anesthesia Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Intravenous Injection General Anesthesia Drugs by Type (2020-2031)
 Figure 57. Global Intravenous Injection General Anesthesia Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Intravenous Injection General Anesthesia Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Intravenous Injection General Anesthesia Drugs by Application (2020-2031)
 Figure 60. Global Intravenous Injection General Anesthesia Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 61. Intravenous Injection General Anesthesia Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Injection General Anesthetics Drug Market Research Report 2024
Global Intravenous Gemeral Anesthetics Drug Market Research Report 2024
Global Intravenous Anesthetic Market Research Report 2025
Global Intravenous Anesthetics Market Research Report 2024
Global General Anesthesia Drugs Market Research Report 2025
General Anaesthetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Total Intravenous Anesthesia TIVA Market Research Report 2024
Global Injection Anesthetics Drug Market Research Report 2024
General Anesthetic for Surgery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalation General Anesthesia Drugs Market Research Report 2024
Injectable Anesthetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
General Anaesthetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Propofol Injection for Operation General Anesthesia Market Insights Forecast to 2030
Global Inhalation Anesthesia Drugs Market Research Report 2024
Global Inhalational Anaesthesia Drugs Market Research Report 2024
Global General Anaesthesia Drugs Market Research Report 2024
General Anesthesia Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Continuous flow Anaesthetic Machine Market Insights Forecast to 2030
Global Alternate site Infusion Therapy Market Insights Forecast to 2030
Global Inhalational Anesthesia Drugs Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions